Patients should also understand realistic expectations for these medications
however, mortality was rare
In a large retrospective analysis of patients with T2DM who had received GLP-1 based therapy (n = 461,382), over 20 % of patients had nutritional deficiencies diagnosed within one year of starting treatment, with Vitamin D deficiency the most common (14 % of patients at one year), and 3 % of patients were diagnosed with muscle loss within one year [69]
Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in alzheimers disease
Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis
Subsequent trials, including SUSTAIN-6, Harmony Outcomes, and AMPLITUDE-O, reported similar MACE reductions but without a mortality benefit [15,16,17]